PURPOSE: The purpose of the present study was to prospectively compare the predictive accuracy of static venous pressure (SVP); dynamic venous pressure (DVP) and access blood flow (ABF) in determining subsequent graft thrombosis and/or failure. METHODS: This study included 43 patients with functional arteriovenous grafts (AVG's) who underwent monthly seri-al measurements of SVP, DVP and ABF for 3 consecutive months. Patients were then followed for an additional 6 months. The primary end point was graft thrombosis. RESULTS: Six patients were excluded from the final analysis. Of the 37 patients completing the study, 7 episodes of graft thrombosis occurred within 6 months of follow up. Neither SVP nor DVP exhibited satisfactory sensitivity or specificity for graft thrombosis. Ten patients either began with or developed an ABF < 600 during the 3 months of measurements, but only 5 clotted. delta ABF of >20% provided the best combination of sensitivity (86%) and specificity (90%) for graft thrombosis. In AVG's that have an ABF<600, it is those grafts with falling ABF that appear most likely to clot in the short term. CONCLUSION: The study supports the concept that it is a falling level of access flow rather than the absolute level that is the most potent predictor of graft thrombosis.
PURPOSE: The purpose of the present study was to prospectively compare the predictive accuracy of static venous pressure (SVP); dynamic venous pressure (DVP) and access blood flow (ABF) in determining subsequent graft thrombosis and/or failure. METHODS: This study included 43 patients with functional arteriovenous grafts (AVG's) who underwent monthly seri-al measurements of SVP, DVP and ABF for 3 consecutive months. Patients were then followed for an additional 6 months. The primary end point was graft thrombosis. RESULTS: Six patients were excluded from the final analysis. Of the 37 patients completing the study, 7 episodes of graft thrombosis occurred within 6 months of follow up. Neither SVP nor DVP exhibited satisfactory sensitivity or specificity for graft thrombosis. Ten patients either began with or developed an ABF < 600 during the 3 months of measurements, but only 5 clotted. delta ABF of >20% provided the best combination of sensitivity (86%) and specificity (90%) for graft thrombosis. In AVG's that have an ABF<600, it is those grafts with falling ABF that appear most likely to clot in the short term. CONCLUSION: The study supports the concept that it is a falling level of access flow rather than the absolute level that is the most potent predictor of graft thrombosis.
Authors: Franklin G Mora-Bravo; Alfonso Mariscal; Juan P Herrera-Felix; Salvador Magaña; Guadalupe De-La-Cruz; Nelly Flores; Laura Rosales; Martha Franco; Héctor Pérez-Grovas Journal: BMC Nephrol Date: 2008-11-24 Impact factor: 2.388